You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Host-Targeted Antiviral Drugs Providing Rapid, Scalable, Stable, Broad-Spectrum MedicalCountermeasure Against Marburg Virus
SBC: EVRYS BIO LLC Topic: CBD18A002In a pandemic or exposure to weaponized Marburg virus the morbidity, mortality and social unrest that will ensue before vaccines orMilitary operating on foreign soil as well as to the population of the US Homeland. Practically all threat agents of biological origin (except forcertain non-proteinaceous toxins, typically produced by marine organisms and fungi) have their structure and vital function ...
STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense -
Additive Manufacturing of Made-To-Measure Respiratory Protection Systems
SBC: AZUL 3D INC Topic: CBD181001CDJ Technologies is an additive manufacturing (AM) company with technology that enables rapid printing over large build volumes. Thisresultant production throughput is differentiating within the AM technology space and enables the adoption of AM technology to addresslimited production-runs. There exist many items where the ability to customize a single component of a system can add substantial val ...
SBIR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense -
Microfiber-Based Closures with Hermetic Sealing for Chem Bio Protective Garments
SBC: NANOGRIPTECH Topic: CBD13109Future engagements (especially with near-peer threats) present the possibility of a wide range of anticipated operational situations involving the presence of chemical threat agents. With this, deployment of Military Working Dogs (MWDs) is likely. This creates a situational awareness that MWDs are potentially at risk from exposure to a wide range of hazardous chemicals. Potential threat agents inc ...
SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense -
Medical Countermeasure Development for Viral Induced Encephalitis Using Single DomainAntibodies
SBC: ABZYME THERAPEUTICS LLC Topic: CBD161004Alphaviruses, infection with which may cause encephalitis and death, are recognized as potential biological warfare agents. There are noapproved medical countermeasures against Alphaviruses. In Phase I, using Abzymes proprietary in vivo Self-Diversifying Camelid SingleDomain Antibody Library (SDALib) platform, broadly reactive single domain camelid VHH antibodies against equine encephalitis viral ...
SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense -
Dermal Medical Countermeasures for Chemical Weapons Exposure
SBC: ZYMERON CORP Topic: CBD161003The skin is the first line of defense against chemical warfare agents including nerve agents and toxic industrial chemicals, providing a possible barrier or delay to systemic distribution. Some chemicals also can act directly on the skin including the vesicants sulfur mustard and lewisite. Early and rapid skin decontamination is extremely important following exposure to CWAs and TICs because it de ...
SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense -
Decontamination Assurance Spray
SBC: AGENTASE LLC Topic: CBD05103There are many products that can identify chemical weapons. They range in complexity from simple colorimetric chemical test strips or gas tubes, to more complex multi-step test kits, to intricate arrays of gas chromatographs and mass spectrometers. None of the products is specifically designed to illustrate the presence of chemicals on surfaces or have use as a decontamination assurance method. ...
SBIR Phase I 2005 Department of DefenseOffice for Chemical and Biological Defense -
Analysis Tools for Detection and Diagnosis of Biological Threats
SBC: ALPHA-GAMMA TECHNOLOGIES, INC. Topic: CBD04113DNA microarray technology, in combination with statistical and predictive modeling tools, could be used to evaluate thousands of genes against distinct gene expression patterns induced by chemical/biological agents to provide early identification and speed therapeutic intervention. The overall objective of this Phase II effort is to leverage existing public domain resources and commercial tools t ...
SBIR Phase II 2005 Department of DefenseOffice for Chemical and Biological Defense -
Novel THz-frequency spectrometers by integrating widely-tunable monochromatic THz sources and detectors, or arrays of emitters and detectors, with pho
SBC: ArkLight Topic: CBD04104By continuing teaming up with one of the most reputable university teams in THz science and technology, ArkLight proposes to carry out the tasks set for a Phase-II program following our success in Phase I. We are aimed at the further development of novel spectrometers to analyze chemicals in the vapor phase based on accurate measurements of the emission and absorption spectra due to the molecular ...
SBIR Phase II 2005 Department of DefenseOffice for Chemical and Biological Defense -
Handheld Photoacoustic Chemical Agent and Toxic Industrial Material Detector
SBC: MANNING APPLIED TECHNOLOGY Topic: CBD05112Manning Applied Technology proposes to develop a handheld infrared spectrometer, ideally suited to detection of airborne chemical agents at and below permissible exposure limits. This approach offers unmatched sensitivity and specificity for detection of all types of chemical vapors. The instrument is modular, rugged, compact and highly sensitive. Volume pricing will be less than $1000 each. ...
SBIR Phase I 2005 Department of DefenseOffice for Chemical and Biological Defense -
Imidazenil: A Protective Agent Against Chemical Warfare Agents induced Status Epilepticus
SBC: NEUPHARMA, INC. Topic: CBD05116The overall objective of this proposal is to demonstrated that imidazenil is a more potent and safer protective agent than diazepam against chemical warfare nerve agent (CWNA)-induced seizure/status epilepticus, neuropathology, and neurobehavioral deficits. Thus we will compare the dose-dependent efficacy of imidazenil or diazepam administered alone and in combination with levetiracetam in protect ...
SBIR Phase I 2005 Department of DefenseOffice for Chemical and Biological Defense